Comparable Efficacy of Low- Versus High-Dose Induction Corticosteroid Treatment in Autoimmune Pancreatitis
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The objective of this study was to compare efficacy of high versus low doses of prednisone for induction of remission in autoimmune pancreatitis (AIP). METHODS: This is a retrospective, multicenter study including patients diagnosed with AIP between May 1992 and August 2011. Clinical, laboratory and imaging findings were assessed before treatment and at 1, 3, and 6 months after starting treatment. RESULTS: A total of 65 patients (57 males; median age, 63 years) were treated with an initial low dose (10-20 mg/d, n = 14), a medium dose (30 mg/d, n = 15), or a high dose (40-60 mg/d, n = 36) of prednisone. There were no significant differences in baseline characteristics between the treatment groups including age, presenting symptoms and laboratory results. During a follow-up period of 6 months, in nearly all patients, symptoms (jaundice, weight loss) resolved completely. After 6 months, treatment response with respect to symptomatic, radiological, and laboratory improvement was comparable for the different dosage groups. CONCLUSIONS: Response to therapy was comparable for AIP patients treated with doses of prednisone in the range of 10 to 60 mg/d. A prospective trial should be conducted to confirm efficacy of lower-dose prednisone treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“retrospective analyses from the Netherlands indicated that initial doses of 10-20 mg predniso(lo)ne daily may be as effective in controlling at least type 1 autoimmune pancreatitis and preventing disease relapse.280”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [280]
Citations
Cites
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Shimosegawa, T., Chari, S. T., Frulloni, L., Kamisawa, T., Kawa, S., Mino-Kenudson, M., Kim, M.-H., Klöppel, G., Lerch, M. M., Löhr, M., et al. (2011) · Pancreas · doi:10.1097/mpa.0b013e3182142fd2 · Cited by 1,526
Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates
Boumpas, D. T., Chrousos, G. P., Wilder, R. L., Cupps, T. R., & Balow, J. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-12-199312150-00007 · Cited by 778
Standard steroid treatment for autoimmune pancreatitis
Kamisawa, T., Shimosegawa, T., Okazaki, K., Nishino, T., Watanabe, H., Kanno, A., Okumura, F., Nishikawa, T., Kobayashi, K., Ichiya, T., et al. (2009) · Gut · doi:10.1136/gut.2008.172908 · Cited by 724
Otsuki, M., Chung, J. B., Okazaki, K., Kim, M.-H., Kamisawa, T., Kawa, S., Park, S. W., Shimosegawa, T., Lee, K., Ito, T., et al. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2205-6 · Cited by 425
Autoimmune related pancreatitis: Table 1
Okazaki, K., & Chiba, T. (2002) · Gut · doi:10.1136/gut.51.1.1 · Cited by 417
Glucocorticoids and the risk for initiation of hypoglycemic therapy
Gurwitz, J. H. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420010131015 · Cited by 314
Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment
Hirano, K., Tada, M., Isayama, H., Yagioka, H., Sasaki, T., Kogure, H., Nakai, Y., Sasahira, N., Tsujino, T., Yoshida, H., et al. (2007) · Gut · doi:10.1136/gut.2006.115246 · Cited by 283
Working members of Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society, Kamisawa, T., Okazaki, K., Kawa, S., Shimosegawa, T., & Tanaka, M. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0221-9 · Cited by 260
Sclerosing pancreato-cholangitis responsive to steroid therapy
Erkelens, G., Vleggaar, F., Lesterhuis, W., van Buuren, H., & van der Werf, S. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00603-0 · Cited by 239
Self-citation
Cited by
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Self-citationRecent Advances in Autoimmune Pancreatitis
Hart, P. A., Zen, Y., & Chari, S. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.010 · Cited by 400
Advances in the diagnosis and management of IgG4 related disease
Lanzillotta, M., Mancuso, G., & Della-Torre, E. (2020) · BMJ · doi:10.1136/bmj.m1067 · Cited by 360
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations
Löhr, J., Beuers, U., Vujasinovic, M., Alvaro, D., Frøkjær, J. B., Buttgereit, F., Capurso, G., Culver, E. L., de‐Madaria, E., Della‐Torre, E., et al. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620934911 · Cited by 252
Self-citationInternational consensus for the treatment of autoimmune pancreatitis
Okazaki, K., Chari, S. T., Frulloni, L., Lerch, M. M., Kamisawa, T., Kawa, S., Kim, M.-H., Lévy, P., Masamune, A., Webster, G., et al. (2017) · Pancreatology · doi:10.1016/j.pan.2016.12.003 · Cited by 249
Clinical practice guidelines for IgG4‐related sclerosing cholangitis
Kamisawa, T., Nakazawa, T., Tazuma, S., Zen, Y., Tanaka, A., Ohara, H., Muraki, T., Inui, K., Inoue, D., Nishino, T., et al. (2019) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.596 · Cited by 180
Beyer, G., Hoffmeister, A., Michl, P., Gress, T. M., Huber, W., Algül, H., Neeße, A., Meining, A. G., Seufferlein, T. T. W., Rosendahl, J., et al. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1735-3864 · Cited by 128
On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease
Trampert, D. C., Hubers, L. M., van de Graaf, S. F. J., & Beuers, U. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.038 · Cited by 117
Self-citationNagpal, S. J. S., Sharma, A., & Chari, S. T. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0146-0 · Cited by 106
IgG4-related hepatobiliary disease: an overview
Culver, E. L., & Chapman, R. W. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.132 · Cited by 97
Gastrointestinal and Extra-Intestinal Manifestations of IgG4–Related Disease
Miyabe, K., Zen, Y., Cornell, L. D., Rajagopalan, G., CHOWDHARY, V. R., Roberts, L. R., & Chari, S. T. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.082 · Cited by 89
Madhani, K., & Farrell, J. J. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.10.005 · Cited by 72
Emerging therapy options for IgG4-related disease
Lanzillotta, M., Fernández‐Codina, A., Culver, E. L., Ebbo, M., Martínez‐Valle, F., SCHLEINITZ, N., & Della‐Torre, E. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1902310 · Cited by 54
Buijs, J., Cahen, D. L., Heerde, M. J. V., Rauws, E. A., Wenniger, L. J. M. D. B., Hansen, B. E., Biermann, K., Verheij, J., Vleggaar, F. P., Brink, M. A., et al. (2015) · Pancreas · doi:10.1097/mpa.0000000000000451 · Cited by 53
Self-citationType 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment
Overbeek, K. A., Poulsen, J. L., Lanzillotta, M., Vinge-Holmquist, O., Mačinga, P., Demirci, A. F., Sindhunata, D. P., Backhus, J., Algül, H., Buijs, J., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.12.010 · Cited by 50
Self-citationUpdate on Autoimmune Pancreatitis and IgG4‐Related Disease
Lanzillotta, M., Vujasinović, M., Löhr, M. J., & Della‐Torre, E. (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12738 · Cited by 50
Yoshifuji, H., & Umehara, H. (2022) · Modern Rheumatology · doi:10.1093/mr/roac097 · Cited by 45
Management of Autoimmune Pancreatitis
Madhani, K., & Farrell, J. J. (2018) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2018.05.002 · Cited by 34
IgG4-Associated Cholangitis - A Mimic of PSC
Beuers, U. H., Hubers, L. M., Doorenspleet, M. E., Wenniger, L. J. M. D. B., Klarenbeek, P. L., Boonstra, K., Ponsioen, C. Y., Rauws, E. A., & de Vries, N. (2015) · Digestive Diseases · doi:10.1159/000440830 · Cited by 32
Self-citationRasch, S., Phillip, V., Schmid, R. M., & Algül, H. (2015) · Pancreatology · doi:10.1016/j.pan.2015.11.006 · Cited by 27
Recent advances in understanding and managing IgG4-related disease
Wolfson, A. R., & Hamilos, D. L. (2017) · F1000Research · doi:10.12688/f1000research.9399.1 · Cited by 24
Diagnosis and Management of Autoimmune Pancreatitis
Hart, P. A., Krishna, S. G., & Okazaki, K. (2017) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-017-0147-x · Cited by 19
PrescrAIP: A Pan-European Study on Current Treatment Regimens of Auto-Immune Pancreatitis
Lanzillotta, M., Vinge-Holmquist, O., Overbeek, K. A., Poulsen, J. L., Demirci, A. F., Mačinga, P., Löhr, M. J., & Rosendahl, J. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00408 · Cited by 17
Maintenance therapy in autoimmune pancreatitis: a weak light into the darkness
Frulloni, L., de Pretis, N., & Amodio, A. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.07.06 · Cited by 13
Management of IgG4-related cholangitis: diagnosis, therapy, and long-term surveillance
Herta, T., Schröder, M., Geisel, D., Engelmann, C., & Tacke, F. (2025) · Gastroenterology report · doi:10.1093/gastro/goaf032 · Cited by 12
Immunoglobulin G4-related cholangiopathy: clinical and experimental insights
Wenniger, L. J. M. D. B., & Beuers, U. H. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000170 · Cited by 11
Self-citationRecent developments in steroid-responsive pancreatitides (autoimmune pancreatitis)
Sah, R. P., & Chari, S. T. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000205 · Cited by 6
Autoimmune Pancreatitis Masquerading as Pancreatic Cancer: A Case Report and Literature Review
Agarwal, K. K., Jassal, R., Browne, A. S., Hossain, M., & Akhtar, R. Y. (2022) · Cureus · doi:10.7759/cureus.21900 · Cited by 5
Nagpal, S. J. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_115 · Cited by 5
What Is the Latest in Autoimmune Pancreatitis
Mills, K. C., & Majumder, S. (2024) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2024.08.021 · Cited by 4
IgG4-assoziierte Cholangitis – klinische Präsentation eines lange übersehenen Krankheitsbildes
Herta, T., Verheij, J., & Beuers, U. H. (2018) · Der Internist · doi:10.1007/s00108-018-0431-4 · Cited by 4
Self-citationIgG4-related disease: the state of art
Zykova, A., Novikov, P., Brovko, M., Анатольевна, А. Л., & Moiseev, S. V. (2020) · Clinical pharmacology and therapy · doi:10.32756/0869-5490-2020-3-4-13 · Cited by 4
Challenges for clinicians treating autoimmune pancreatitis: Current perspectives
Kim, S., Lee, Y. C., & Chon, H. K. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i1.30 · Cited by 4
Iwasa, Y., Iwashita, T., Iwata, K., Tezuka, R., Uemura, S., Maruta, A., Iwata, S., Ohashi, Y., Yoshida, K., & Shimizu, M. (2025) · Diagnostics · doi:10.3390/diagnostics15212719 · Cited by 2
Autoimmunassoziierte Gallenwegserkrankungen: Diagnostische und therapeutische Herausforderungen
Herta, T., & Beuers, U. H. (2019) · Der Radiologe · doi:10.1007/s00117-019-0513-x · Cited by 2
Self-citationMimickers of immunoglobulin G4-related hepatobiliary disease on biopsy
Park, B. U., Lee, H. E., & Zhang, L. (2024) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2024.01.009 · Cited by 1
Immunoglobulin G4: Cross Talk in Hearing Loss Manifestation
Barfejani, A. H., & Ghobadi, A. (2025) · Indian Journal of Otology · doi:10.4103/indianjotol.indianjotol_204_24 · Cited by 1
Hirano, K., Kondo, K., Saito, T., Takahashi, K., Ono, S., Abe, S., Kato, T., Kobayashi, K., Sekigawa, K., & Mitsui, H. (2026) · Internal Medicine · doi:10.2169/internalmedicine.6704-25 · Cited by 1
Lee, L., Ito, T., Igarashi, H., Hijioka, M., Ueda, K., Fujiyama, T., Tachibana, Y., HASHIMOTO, R., Takamatsu, Y., Yasunaga, K., et al. (2015) · Suizo · doi:10.2958/suizo.30.85 · Cited by 1
REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Hart, P. A., Zen, Y., & Chari, S. T. (2015) · Cited by 1
[Treatment and prognosis of immunoglobulin G4-related hepatobiliary disease].
Gong, L., & Shi, J. P. (2018) · PubMed Central · doi:10.3760/cma.j.issn.1007-3418.2018.06.004 · Cited by 1
Potential roles of antibodies with different classes in IgG4‐related diseases
Li, L., Cai, S., Lin, S., Bai, L., Yu, Z., Sun, W., & Dong, L. (2025) · Rheumatology & autoimmunity · doi:10.1002/rai2.70003 · Cited by 1
The Great Pretender: Autoimmune Pancreatitis
Azzopardi, N. (2014) · OAR@UM (University of Malta)
IgG4-Related Sclerosing Cholangitis in Europe
de Pretis, N., Amodio, A., Marchi, G. D., & Frulloni, L. (2018) · Springer eBooks · doi:10.1007/978-981-10-4548-6_21
IgG4‐Related Liver and Biliary Disease
Barnes, E. J., & Culver, E. L. (2020) · Wiley eBooks · doi:10.1002/9781119532637.ch9
IgG4-Erkrankung des Verdauungstrakts
Beuers, U. H., & Herta, T. (2021) · Elsevier eBooks · doi:10.1016/b978-3-437-23847-5.00051-x
Self-citationNagpal, S. J. S. (2021) · Springer eBooks · doi:10.1007/978-3-319-90761-1_115-1
Garg, S. K., & Chari, S. T. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780192858443.003.0007
Maladie associée aux IgG4 : une maladie protéiforme aux manifestations thoraciques fréquentes
Groh, M., Habert, P., Ebbo, M., Muller, R., Gaigne, L., Gaubert, J.-Y., & SCHLEINITZ, N. (2023) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2023.10.001
IgG4-Erkrankung des Verdauungstrakts
Beuers, U. H., & Herta, T. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21005-1.00054-8
Self-citationPankreasın Cerrahi Hastalıkları
Çöpelci, Y., Özşay, O., Daban, U., Varman, A., Alkan, S., Sürmeli, S., Tunç, E., Yalçın, M., Dursun, A., Göztok, M., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.1348
Archer, S. R. E. S. D. O. B. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/t7nd-e819
Appelt, T., Ceyhan, G. O., & München, T. U. (2021) · mediaTUM (Technical University of Munich)
IgG4-related disease of the biliary tract and pancreas: Catching a great mimicker
Hubers, L. M., Beuers, U. H., & van de Graaf, S. F. J. (2021) · Pure Amsterdam UMC
Self-citationPeriarteritis/periaortitis y fibrosis retroperitoneal en enfermedad relacionada por IgG4
Zunino, L. V., & Paira, S. O. (2023) · Revista Cubana de Reumatología: RCuR
Otological Manifestations of Immunoglobulin G4-related Disease: A Review
Swain, S. K. (2026) · Dr Sulaiman Al Habib Medical Journal · doi:10.4103/dshmj.dshmj_17_26
Iwasa, Y., Maruta, A., Iwata, K., Kuroda, H., Uemura, S., Iwata, S., Ohashi, Y., Mita, N., Ichikawa, H., & Shimizu, M. (2026) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.70186
Disentangling inflammatory drivers of fibrosis in IgG4-related disease
LANZILLOTTA, M. (n.d.) · Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele
Metadata
- Authors
- Buijs, J., van Heerde, M. J., Rauws, E. A. J., de Buy Wenniger, L. J. M., Hansen, B. E., Biermann, K., Verheij, J., Vleggaar, F. P., Brink, M. A., Beuers, U. H. W., Kuipers, E. J., Bruno, M. J., & van Buuren, H. R.
- Affiliations
- Erasmus MC (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Meander Medisch Centrum (NL)
- University Medical Center Utrecht (NL)
- Corresponding author
- Buijs, Jorie
- Hansen, Bettina E.
- Kuipers, Ernst J.
- Bruno, Marco J.
- ORCID
- Venue
- Pancreas
- Published
- 2014-03
- Volume
- 43
- Issue
- 2
- Pages
- 261-267
- ISSN
- 0885-3177 (ISSN-L)
- OpenAlex
- W2008022161
- Cited by
- 51
- References
- 24
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 6 · 2019: 1 · 2018: 6 · 2017: 3 · 2016: 3 · 2015: 8 · 2014: 1
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Pancreas (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Health Sciences › Medicine › Clinical Neurology › Myasthenia Gravis and Thymoma
- Keywords
- autoimmune pancreatitis, prednisone, induction therapy, corticosteroid dose, low-dose prednisone, remission induction, treatment response, jaundice, weight loss
- MeSH terms
- Adult, Aged, Autoimmune Diseases, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Glucocorticoids, Humans, Jaundice, Male, Middle Aged, Pancreatitis, Prednisone, Retrospective Studies, Time Factors, Weight Loss, Treatment Outcome, Induction Chemotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.